About Clarity Genomics Inc
Experts in Microbiome Research and Bioinformatics
Our mission is to empower the development of microbiome-based therapeutics through comprehensive data analysis and innovative bioinformatics solutions.
We strive to unlock the potential of the microbiome and metabolome, driving advancements in health and wellness.
What We Bring to the Table
Deep Expertise in Host–Microbiome Interactions
Our team brings together specialists in mass spectrometry, DNA sequencing, and bioinformatics to uncover how microbes and their hosts communicate - enabling precise insights for drug discovery and therapeutic development.
Integrated Multi-Omics Analysis
We combine microbiome, metabolome, and proteome data through advanced computational pipelines to reveal actionable biomarkers and metabolic pathways with clinical relevance.
Machine Learning for Predictive Therapeutic Insights
Using AI-driven models and covariate analysis, we identify microbial and molecular patterns that predict disease states, treatment response, and product efficacy.
Trusted by Leading Pharma and Research Partners
From biotech startups to Fortune 500 pharmaceutical companies, Clarity Genomics is a trusted collaborator delivering reproducible, data-driven results that accelerate microbiome-based innovation.
Our Story
Clarity Genomics was founded in 2016 out of the University of California San Diego, with the mission of translating cutting-edge microbiome and metabolomics research into practical applications.
From the beginning, our focus has been on bridging DNA sequencing and metabolomic profiling to understand how microbial communities interact with their chemical environments and the human host. That scientific foundation continues to shape our approach today.
In 2016, Clarity Genomics was selected into UC San Diego’s Rady School of Management StartR accelerator, where we developed our business model and refined our service offering. The following year, we joined Johnson & Johnson Innovation - JLABS, gaining access to a vibrant community of startups and researchers advancing microbiome-based therapeutics. Working alongside these innovators allowed us to sharpen our focus and specialize in microbiome-metabolome interaction analysis, integrating robust sequencing analytics with state-of-the-art mass spectrometry and secure, reproducible bioinformatics pipelines.
Since then, Clarity Genomics has partnered with organizations ranging from early-stage biotechs to global pharmaceutical and consumer health companies. We help our partners design studies, analyze complex multi-omic datasets, and uncover meaningful biological insights that link microbial function to human health and disease.
Our goal remains the same as it was at the start - to transform complex microbiome and metabolome data into clear, actionable understanding.
Connect With Us
Connect with Clarity Genomics to explore how our expertise in microbiome-metabolome data analysis can elevate your next project.